Mortality caused by extended-spectrum beta-lactamase–producing Enterobacteriaceae bacteremia; a case control study: alert to Enterobacteriaceae strains with high minimum inhibitory concentrations of piperacillin/tazobactam-Reference-Cited by-同舟云学术

Mortality caused by extended-spectrum beta-lactamase–producing Enterobacteriaceae bacteremia; a case control study: alert to Enterobacteriaceae strains with high minimum inhibitory concentrations of piperacillin/tazobactam

Published:2019-07 Issue:3 Volume:94 Page:287-292
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Namikawa Hiroki,Yamada Koichi,Yamairi Kazushi,Shibata Wataru,Fujimoto Hiroki,Takizawa Etsuko,Niki Makoto,Nakaie Kiyotaka,Oinuma Ken-Ichi,Niki Mamiko,Takemoto Yasuhiko,Kaneko Yukihiro,Shuto Taichi,Kakeya Hiroshi

Funder

Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency Development

AMED

JSPS KAKENHI

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Severe sepsis and septic shock;Angus;N Engl J Med,2013

2. Fever of unknown origin in febrile leukopenia;Antoniadou;Infect Dis Clin N Am,2007

3. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients;Ben-Ami;Clin Infect Dis,2009

4. Association between dementia and reduced walking ability and 30-day mortality in patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia;Chapelet;Eur J Clin Microbiol Infect Dis,2017

5. Performance standards for antimicrobial susceptibility testing; 26th informational supplement. M100-S26;Clinical and Laboratory Standards Institute (CLSI),2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiological analysis and antimicrobial susceptibility profile of Gram-negative bacilli that cause bacteremia in Japan;Journal of Infection and Chemotherapy;2023-12

2. In vitro efficacy of humanized regimen of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae;Antimicrobial Agents and Chemotherapy;2023-09-19

3. Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia;Emerging Microbes & Infections;2023-06-05

4. Systematic Literature Review of the Association of Fever and Elevated Temperature with Outcomes in Critically Ill Adult Patients;Therapeutic Hypothermia and Temperature Management;2023-05-09

5. Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?;Healthcare;2022-05-05